Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Panacea Biotec Limited (PANACEABIO) Stock Price & Analysis

0 Followers

PANACEABIO Stock Chart & Stats

₹354.55-₹7.00(-1.94%)
At close: 3:30 PM GMT+5:30
₹300₹350₹400Aug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 353.00 - INR 361.75
52-Week Range
INR 293.10 - INR 647.50
Previous Close
INR 361.55
Volume
N/A
Average Volume (3M)
3,267
Market Cap
INR 22.15B
Enterprise Value
INR 17.33B
Total Cash (Recent Filing)
INR 744.00M
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
―
Beta
1.21
Next Earnings
Nov 14, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 19, 2011
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery

Revenue recovery indicates that the company has regained commercial traction after the FY2023 base. Continued top-line expansion can broaden operating scale and support better fixed-cost absorption, although conversion into sustainable profit remains necessary.

Conservative Balance Sheet

Very low leverage and stable equity provide financial flexibility through operating volatility. This reduces interest and refinancing pressure, preserves capacity to fund products and operations, and gives the company more time to improve profitability without heavy balance-sheet strain.

Diversified Biopharma Platform

A portfolio spanning formulations, vaccines, and biologics creates multiple avenues for commercialization rather than dependence on one product category. In-house R&D and manufacturing also support control across development and production as the company expands across markets.

Bears Say

Persistent Unprofitability

Revenue growth has not yet translated into positive operating or bottom-line earnings. Persistent losses weaken internal capital generation, limit the ability to compound equity value, and indicate that cost structure or product economics still require meaningful improvement.

Negative Free Cash Flow

Repeatedly negative free cash flow shows that the business has absorbed cash over an extended period rather than consistently funding itself. If this continues, investment and operating needs may consume financial flexibility and increase dependence on existing balance-sheet resources.

Volatile Earnings Quality

The FY2022 profit was not sustained, while subsequent negative operating cash flow underscores uneven earnings quality. This volatility makes performance less predictable and suggests that revenue gains have not yet produced a dependable, repeatable profit model.

Panacea Biotec Limited News

PANACEABIO FAQ

What was Panacea Biotec Limited’s price range in the past 12 months?
Panacea Biotec Limited lowest stock price was ₹293.10 and its highest was ₹647.50 in the past 12 months.
What is Panacea Biotec Limited’s market cap?
Panacea Biotec Limited’s market cap is ₹22.15B.
When is Panacea Biotec Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Panacea Biotec Limited’s earnings last quarter?
Panacea Biotec Limited released its earnings results on Aug 13, 2026. The company reported ₹0.376 earnings per share for the quarter.
Is Panacea Biotec Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Panacea Biotec Limited pay dividends?
Panacea Biotec Limited pays an annual dividend of ₹0.75 which represents an annual dividend yield of ―. See more information on Panacea Biotec Limited dividends here
What is Panacea Biotec Limited’s EPS estimate?
Panacea Biotec Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panacea Biotec Limited have?
Panacea Biotec Limited has 61,250,744 shares outstanding.
What happened to Panacea Biotec Limited’s price movement after its last earnings report?
Panacea Biotec Limited reported an EPS of ₹0.376 in its last earnings report. Following the earnings report the stock price went up 3.5%.
Which hedge fund is a major shareholder of Panacea Biotec Limited?
Currently, no hedge funds are holding shares in IN:PANACEABIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology